Veracyte, Inc.
    SEC Filings

    Log in to see pricing

    All SEC filings by Veracyte, Inc. (VCYT) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.

    Financials

    10-QQuarterly reportView DiffNov 5, 2026
    10-QQuarterly reportView DiffJul 31, 2026
    10-QQuarterly reportView DiffMay 6, 2026
    ARSAnnual report to shareholdersApr 22, 2026
    10-KAnnual reportView DiffFeb 26, 2026
    10-QQuarterly reportView DiffNov 5, 2025
    10-QQuarterly reportView DiffAug 7, 2025
    10-QQuarterly reportView DiffMay 8, 2025
    ARSAnnual report to shareholdersApr 29, 2025
    10-KAnnual reportView DiffFeb 27, 2025

    Events

    8-KVeracyte Announces Third Quarter 2026 Financial ResultsNov 4, 2026
    8-KVeracyte Acquires Convergent Genomics, Expanding Its Urology Diagnostics Portfolio with a Urinary Tumor Dna Testing PlatformSep 14, 2026
    8-KVeracyte Announces Second Quarter 2026 Financial ResultsJul 30, 2026
    8-KCurrent reportJun 11, 2026
    8-KVeracyte Announces First Quarter 2026 Financial ResultsMay 5, 2026
    8-KDeparture of Directors or Certain OfficersMar 16, 2026
    8-KVeracyte Announces Fourth Quarter and Full Year 2025 Financial ResultsFeb 25, 2026
    8-KVeracyte Announces Preliminary Fourth Quarter and Full-Year 2025 ResultsJan 12, 2026
    8-KVeracyte Announces Third Quarter 2025 Financial ResultsNov 4, 2025
    8-KVeracyte Announces Second Quarter 2025 Financial ResultsAug 6, 2025

    Registrations and Prospectuses

    S-8Registration of securities for employeesJun 10, 2026
    S-8Registration of securities for employeesJun 17, 2025
    S-8Registration of securities for employeesJun 12, 2024
    424B7Prospectus with selling stockholder infoMar 22, 2024
    424B7Prospectus with selling stockholder infoFeb 29, 2024
    S-8Registration of securities for employeesFeb 29, 2024
    S-3ASRAutomatic shelf registrationFeb 29, 2024
    S-8 POSRegistration of securities for employees (post-effective amendment)Jun 8, 2023
    S-8 POSRegistration of securities for employees (post-effective amendment)Jun 8, 2023
    S-8 POSRegistration of securities for employees (post-effective amendment)Jun 8, 2023

    Proxies

    DEFA14AProxy FilingApr 22, 2026
    DEF 14AAnnual Meeting of ShareholdersView DiffApr 22, 2026
    DEFA14AAdditional proxy soliciting materialsApr 29, 2025
    DEF 14ADefinitive proxyView DiffApr 29, 2025
    DEFA14AAdditional proxy soliciting materialsApr 25, 2024
    DEF 14ADefinitive proxyView DiffApr 25, 2024
    DEFA14AAdditional proxy soliciting materialsJun 1, 2023
    DEFA14AAdditional proxy soliciting materialsApr 27, 2023
    DEF 14ADefinitive proxyView DiffApr 27, 2023
    PRE 14APreliminary proxyApr 17, 2023

    Other

    UPLOADLetter from SECJun 13, 2024
    CORRESPCorrespondence with SECJun 7, 2024
    UPLOADLetter from SECMay 28, 2024
    UPLOADLetter from SECSep 20, 2021
    CORRESPCorrespondence with SECSep 9, 2021
    UPLOADLetter from SECAug 27, 2021
    SEC STAFFSEC staff action: OrderFeb 20, 2020
    SEC STAFFSEC staff action: OrderFeb 10, 2020
    SEC STAFFSEC staff action: OrderJun 4, 2019
    SEC STAFFSEC staff action: OrderMay 24, 2019

    Ownership

    SC 13G/AArtisan Partners Limited Partnership Updates Stake in Veracyte, Inc.Nov 12, 2026
    SC 13G/AFmr Llc Updates Stake in Veracyte, Inc.Nov 5, 2026
    4Wygant JonathanOct 29, 2026
    4Holstein JensOct 28, 2026
    4Eastham KarinOct 28, 2026
    144Notice of proposed sale of securitiesOct 27, 2026
    144Notice of proposed sale of securitiesOct 27, 2026
    4Bhanji MunaOct 20, 2026
    144Notice of proposed sale of securitiesSep 24, 2026
    4Leite JohnSep 22, 2026